Kevin Craig
Net worth: 38 220 $ as of 2026-05-30
Net worth: 38 220 $ as of 2026-05-30
Kevin Craig is currently Chief Medical Officer at Atai Beckley, Inc. since 2025.
Formerly, Dr. Craig was Vice President-Clinical Development at Atai Beckley NV from 2021 to 2025, Head-Early Clinical Development at Jazz Pharmaceuticals, Inc., and Senior Director-Neuroscience at Labcorp Drug Development, Inc. Education includes graduate degrees from the University of Cambridge and the University of the Witwatersrand.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0% | 2026-04-19 | 8,437 ( 0% ) | 38 220 $ | 2026-05-30 |
| Companies | Position | Start |
|---|
| Companies | Position | End |
|---|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | - |
| COVANCE INC. | Corporate Officer/Principal | - |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATAI Life Sciences NV
ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions